Valitor

Berkeley, United States

Valitor has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacological properties..

$28.0M raised

Oct 2022

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Valitor raised?

Valitor has raised $28.0M in total funding. The most recent round was Series B. The last funding was announced in October 2022.

Who are Valitor's investors?

Valitor's investors include SkyDeck Berkeley, First Spark Ventures, Berkeley SkyDeck Fund, Berkeley Catalyst Fund (BCF), ExSight Ventures.

Where is Valitor headquartered?

Valitor is headquartered in Berkeley, United States.

What does Valitor do?

Valitor has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacological properties..

What stage is Valitor at?

Valitor is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 5, 2022.

MLA

"Valitor — Funding & Investors." VCBacked, October 5, 2022, https://www.vcbacked.co/company/valitor. Accessed July 2, 2026.

APA

VCBacked. (2022). Valitor — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/valitor

Wikipedia (cite web)

{{cite web |title=Valitor — Funding & Investors |url=https://www.vcbacked.co/company/valitor |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 5, 2022.